Ortin Global has informed that the Board of Directors of the company (Formerly Known as Ortin Laboratories) at its meeting held on Tuesday, 01.04.2025 at 12:45 pm and concluded at 3:15 pm at the Registered Office of the Company, considered and approved the following: 1. Appointment of Madhu Mala Solanki (A49916) as the Company Secretary and Compliance Officer of the Company with effect from 01.04.2025. 2. Resignation of Srinivasa Kumar Sanka as the CFO of the Company with effect from 01.04.2025. (Resignation letter attached as Annexure B). The details required for appointment under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 are enclosed as Annexure A.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1669.05 |
| Dr. Reddys Lab | 1222.65 |
| Cipla | 1230.70 |
| Zydus Lifesciences | 931.80 |
| Lupin | 2323.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: